
Cheng Zhan
Articles
-
Dec 16, 2024 |
pubs.rsc.org | Cheng Zhan
Revisiting the Oxygen Reduction Reaction Activity of Two-Dimensional TM-C2N Electrocatalysts via Constant-Potential Density Functional Theory: Crucial Impact of Spin State and Coordination Single atom catalysts (SACs) have shown great potentiality in catalyzing the oxygen reduction reaction (ORR) in fuel cell batteries.
-
Aug 28, 2024 |
nature.com | Ichitaro Abe |JING CHEN |Linna Zhou |Noelia Martínez-Sánchez |Michael L. Dustin |Cheng Zhan | +5 more
AbstractHuman mutations in neuropeptide Y (NPY) have been linked to high body mass index but not altered dietary patterns1. Here we uncover the mechanism by which NPY in sympathetic neurons2,3 protects from obesity.
-
Jun 2, 2024 |
nature.com | Cheng Zhan
AbstractFerroptosis, a type of iron-dependent non-apoptotic cell death, plays a vital role in both tumor proliferation and resistance to chemotherapy. Here, our study demonstrates that MAX’s Next Tango (MNT), by involving itself in the spermidine/spermine N1-acetyltransferase 1 (SAT1)-related ferroptosis pathway, promotes the proliferation of lung adenocarcinoma (LUAD) cells and diminishes their sensitivity to chemotherapy.
-
Sep 13, 2023 |
dx.doi.org | Wei Guo |Chaochao Dun |Feipeng Yang |Cheng Zhan
Download Hi-Res ImageDownload to MS-PowerPointCite This:ACS Nano 2023, XXXX, XXX Terms & Conditions Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses).
-
May 29, 2023 |
nature.com | Cheng Zhan
AbstractFerroptosis, an iron-dependent non-apoptotic cell death, has been shown to play a vital role in tumor proliferation and chemotherapy resistance. Here, we report that KLF11 inhibits lung adenocarcinoma (LUAD) cell proliferation and promotes chemotherapy sensitivity by participating in the GPX4-related ferroptosis pathway.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →